Cargando…
Preparation of Near-Infrared/Photoacoustic Dual-Mode Imaging and Photothermal/Chemo Synergistic Theranostic Nanoparticles and Their Imaging and Treating of Hepatic Carcinoma
At present, the clinical diagnosis of and treatment methods for hepatic carcinoma still fail to fully meet the needs of patients. The integrated theranostic system, in which functional materials are used to load different active molecules, created a new developmental direction for the combination tr...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485585/ https://www.ncbi.nlm.nih.gov/pubmed/34604095 http://dx.doi.org/10.3389/fonc.2021.750807 |
_version_ | 1784577566959468544 |
---|---|
author | Zhou, Yun Lin, Bixia Li, Kai Zhao, Yufeng Sun, Zhuo He, Chenchen Jha, Rajiv Kumar |
author_facet | Zhou, Yun Lin, Bixia Li, Kai Zhao, Yufeng Sun, Zhuo He, Chenchen Jha, Rajiv Kumar |
author_sort | Zhou, Yun |
collection | PubMed |
description | At present, the clinical diagnosis of and treatment methods for hepatic carcinoma still fail to fully meet the needs of patients. The integrated theranostic system, in which functional materials are used to load different active molecules, created a new developmental direction for the combination treatment of hepatic carcinoma, realizing the synchronization of diagnosis and treatment. In this study, polydopamine (PDA), which has the functions of self-assembly, encapsulation, photothermal conversion, and photoacoustic interaction, was used as the carrier material. The IR780, a near-infrared fluorescence imaging (NIFI), photoacoustic imaging (PAI), and photothermal therapy (PTT) agent, and paclitaxel (PTX), a broad-spectrum chemotherapy drug, were selected to build the NIF/PA dual-mode imaging and PTT/chemo synergistic theranostic nanoparticles (DIST NPs). The DIST NPs have a 103.4 ± 13.3 nm particle size, a weak negative charge on the surface, good colloidal stability, slow and controlled drug release, and high photothermal conversion ability. The experiments results showed that the DIST NPs have a long circulation in vivo, high bioavailability, high biocompatibility, and low effective dose. DIST NPs showed an excellent NIFI/PAI dual-mode imaging and significant synergistic antitumor effect in hepatic carcinoma models. DIST NPs met the initial design requirements. A set of fast and low-cost preparation methods was established. This study provides an experimental basis for the development of new clinical theranostic methods for hepatic carcinoma. |
format | Online Article Text |
id | pubmed-8485585 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84855852021-10-02 Preparation of Near-Infrared/Photoacoustic Dual-Mode Imaging and Photothermal/Chemo Synergistic Theranostic Nanoparticles and Their Imaging and Treating of Hepatic Carcinoma Zhou, Yun Lin, Bixia Li, Kai Zhao, Yufeng Sun, Zhuo He, Chenchen Jha, Rajiv Kumar Front Oncol Oncology At present, the clinical diagnosis of and treatment methods for hepatic carcinoma still fail to fully meet the needs of patients. The integrated theranostic system, in which functional materials are used to load different active molecules, created a new developmental direction for the combination treatment of hepatic carcinoma, realizing the synchronization of diagnosis and treatment. In this study, polydopamine (PDA), which has the functions of self-assembly, encapsulation, photothermal conversion, and photoacoustic interaction, was used as the carrier material. The IR780, a near-infrared fluorescence imaging (NIFI), photoacoustic imaging (PAI), and photothermal therapy (PTT) agent, and paclitaxel (PTX), a broad-spectrum chemotherapy drug, were selected to build the NIF/PA dual-mode imaging and PTT/chemo synergistic theranostic nanoparticles (DIST NPs). The DIST NPs have a 103.4 ± 13.3 nm particle size, a weak negative charge on the surface, good colloidal stability, slow and controlled drug release, and high photothermal conversion ability. The experiments results showed that the DIST NPs have a long circulation in vivo, high bioavailability, high biocompatibility, and low effective dose. DIST NPs showed an excellent NIFI/PAI dual-mode imaging and significant synergistic antitumor effect in hepatic carcinoma models. DIST NPs met the initial design requirements. A set of fast and low-cost preparation methods was established. This study provides an experimental basis for the development of new clinical theranostic methods for hepatic carcinoma. Frontiers Media S.A. 2021-09-17 /pmc/articles/PMC8485585/ /pubmed/34604095 http://dx.doi.org/10.3389/fonc.2021.750807 Text en Copyright © 2021 Zhou, Lin, Li, Zhao, Sun, He and Jha https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Zhou, Yun Lin, Bixia Li, Kai Zhao, Yufeng Sun, Zhuo He, Chenchen Jha, Rajiv Kumar Preparation of Near-Infrared/Photoacoustic Dual-Mode Imaging and Photothermal/Chemo Synergistic Theranostic Nanoparticles and Their Imaging and Treating of Hepatic Carcinoma |
title | Preparation of Near-Infrared/Photoacoustic Dual-Mode Imaging and Photothermal/Chemo Synergistic Theranostic Nanoparticles and Their Imaging and Treating of Hepatic Carcinoma |
title_full | Preparation of Near-Infrared/Photoacoustic Dual-Mode Imaging and Photothermal/Chemo Synergistic Theranostic Nanoparticles and Their Imaging and Treating of Hepatic Carcinoma |
title_fullStr | Preparation of Near-Infrared/Photoacoustic Dual-Mode Imaging and Photothermal/Chemo Synergistic Theranostic Nanoparticles and Their Imaging and Treating of Hepatic Carcinoma |
title_full_unstemmed | Preparation of Near-Infrared/Photoacoustic Dual-Mode Imaging and Photothermal/Chemo Synergistic Theranostic Nanoparticles and Their Imaging and Treating of Hepatic Carcinoma |
title_short | Preparation of Near-Infrared/Photoacoustic Dual-Mode Imaging and Photothermal/Chemo Synergistic Theranostic Nanoparticles and Their Imaging and Treating of Hepatic Carcinoma |
title_sort | preparation of near-infrared/photoacoustic dual-mode imaging and photothermal/chemo synergistic theranostic nanoparticles and their imaging and treating of hepatic carcinoma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485585/ https://www.ncbi.nlm.nih.gov/pubmed/34604095 http://dx.doi.org/10.3389/fonc.2021.750807 |
work_keys_str_mv | AT zhouyun preparationofnearinfraredphotoacousticdualmodeimagingandphotothermalchemosynergistictheranosticnanoparticlesandtheirimagingandtreatingofhepaticcarcinoma AT linbixia preparationofnearinfraredphotoacousticdualmodeimagingandphotothermalchemosynergistictheranosticnanoparticlesandtheirimagingandtreatingofhepaticcarcinoma AT likai preparationofnearinfraredphotoacousticdualmodeimagingandphotothermalchemosynergistictheranosticnanoparticlesandtheirimagingandtreatingofhepaticcarcinoma AT zhaoyufeng preparationofnearinfraredphotoacousticdualmodeimagingandphotothermalchemosynergistictheranosticnanoparticlesandtheirimagingandtreatingofhepaticcarcinoma AT sunzhuo preparationofnearinfraredphotoacousticdualmodeimagingandphotothermalchemosynergistictheranosticnanoparticlesandtheirimagingandtreatingofhepaticcarcinoma AT hechenchen preparationofnearinfraredphotoacousticdualmodeimagingandphotothermalchemosynergistictheranosticnanoparticlesandtheirimagingandtreatingofhepaticcarcinoma AT jharajivkumar preparationofnearinfraredphotoacousticdualmodeimagingandphotothermalchemosynergistictheranosticnanoparticlesandtheirimagingandtreatingofhepaticcarcinoma |